Trade GlaxoSmithKline PLC - GSKl CFD
Add to favourite- Summary
- Historical Data
Spread | 0.040 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023925% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002007% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | GBP | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
Commission on trade | 0% |
Prev. Close | 13.565 |
Open | 13.55 |
1-Year Change | -12.3% |
Day's Range | 13.54 - 13.575 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jan 8, 2025 | 13.565 | 0.025 | 0.18% | 13.540 | 13.605 | 13.405 |
Jan 7, 2025 | 13.435 | 0.000 | 0.00% | 13.435 | 13.645 | 13.180 |
Jan 6, 2025 | 13.470 | 0.095 | 0.71% | 13.375 | 13.475 | 13.240 |
Jan 3, 2025 | 13.370 | -0.180 | -1.33% | 13.550 | 13.655 | 13.360 |
Jan 2, 2025 | 13.330 | -0.075 | -0.56% | 13.405 | 13.645 | 13.330 |
Dec 31, 2024 | 13.390 | 0.115 | 0.87% | 13.275 | 13.455 | 13.275 |
Dec 30, 2024 | 13.340 | 0.015 | 0.11% | 13.325 | 13.445 | 13.285 |
Dec 27, 2024 | 13.330 | -0.030 | -0.22% | 13.360 | 13.435 | 13.135 |
Dec 24, 2024 | 13.320 | -0.065 | -0.49% | 13.385 | 13.450 | 13.320 |
Dec 23, 2024 | 13.295 | 0.150 | 1.14% | 13.145 | 13.360 | 13.145 |
Dec 20, 2024 | 13.210 | 0.155 | 1.19% | 13.055 | 13.220 | 12.990 |
Dec 19, 2024 | 13.035 | -0.165 | -1.25% | 13.200 | 13.315 | 12.990 |
Dec 18, 2024 | 13.310 | -0.025 | -0.19% | 13.335 | 13.370 | 13.210 |
Dec 17, 2024 | 13.190 | 0.315 | 2.45% | 12.875 | 13.430 | 12.875 |
Dec 16, 2024 | 13.185 | 0.035 | 0.27% | 13.150 | 13.265 | 13.090 |
Dec 13, 2024 | 13.295 | 0.000 | 0.00% | 13.295 | 13.340 | 13.210 |
Dec 12, 2024 | 13.355 | 0.000 | 0.00% | 13.355 | 13.385 | 13.190 |
Dec 11, 2024 | 13.385 | -0.235 | -1.73% | 13.620 | 13.660 | 13.385 |
Dec 10, 2024 | 13.590 | -0.250 | -1.81% | 13.840 | 13.965 | 13.590 |
Dec 9, 2024 | 13.580 | 0.140 | 1.04% | 13.440 | 13.845 | 13.435 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GSK Company profile
GlaxoSmithKline PLC - GSK CFD
GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products.
The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of American depositary shares is listed on the New York Stock Exchange.
GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders.
In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives.
Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.
GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.
GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.
GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’
The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.
Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com